| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Ministry of Science and Technology of the People´s Republic of China |
| Information provided by: | Ministry of Science and Technology of the People´s Republic of China |
| ClinicalTrials.gov Identifier: | NCT00745628 |
Purpose
Construction of coronary heart disease cohort of more than 10000 patients in China. Investigation on current situation of secondary prevention of CHD will be carried out and the effect of physician training and patient education will be evaluated.
| Condition |
|
Coronary Heart Diseases |
| MedlinePlus related topics: | Heart Diseases |
| Study Type: | Observational |
| Study Design: | Cohort, Prospective |
| Official Title: | Cross-Sectional Investigation of Secondary Prevention on Coronary Heart Disease and Generalization of Standardized Secondary Prevention in Chinese Coronary Heart Disease Patients |
| Estimated Enrollment: | 10000 |
| Study Start Date: | May 2008 |
| Estimated Study Completion Date: | December 2010 |
| Estimated Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
More than 40 hospitals of 16 provinces will enroll patients for this study. The study will include patients with diagnosed coronary heart disease. Investigators and all the physicians who will involve in daily care of CHD patients will have a brief training on guideline of secondary prevention in CHD and take a test on that. Questionnaires are used to evaluate patient's cognition of their diseases and knowledge on coronary heart disease. Patient education will be carried out during a 2 years follow up of all the patient enrolled before they are required to fill out another questionnaire. Physicians will also take a second test on secondary prevention of CHD at that time. Patients will take blood lipids and glucose test according to their physician's requirement.The effect of physician training and patient education will be evaluated by comparing the results of questionnaires and tests at the beginning of the study and in the end of the 2 years follow up.
Eligibility
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Diagnosed coronary heart disease
Inclusion Criteria:
Exclusion Criteria
Contacts and Locations| Contact: Tao Hong, MD | 86-10-66551122 ext 2229 | dr_hongtao@163.com |
| China | |||||
| Peking University First Hospital | Recruiting | ||||
| Beijing, China, 100034 | |||||
| Contact: Tao Hong 86-10-66551122 ext 2229 dr_hongtao@163.com | |||||
| Ministry of Science and Technology of the People´s Republic of China |
| Principal Investigator: | Tao Hong, MD | Peking University First Hospital |
More Information
| Responsible Party: | Peking University First Hospital ( YHuo,director ) |
| Study ID Numbers: | 2006BAI01A02-08 |
| First Received: | September 2, 2008 |
| Last Updated: | September 2, 2008 |
| ClinicalTrials.gov Identifier: | NCT00745628 |
| Health Authority: | China: Ministry of Health |
|
|
|
|
|
